TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
出版年份 2020 全文链接
标题
TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 24, Pages 9558
出版商
MDPI AG
发表日期
2020-12-16
DOI
10.3390/ijms21249558
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 19th EURETINA Congress Keynote Lecture: Diabetic Retinopathy Today
- (2020) Francesco Bandello et al. OPHTHALMOLOGICA
- Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies
- (2020) Anna A. Plyukhova et al. Journal of Clinical Medicine
- Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors
- (2020) Francesca Lazzara et al. Frontiers in Pharmacology
- Sex Differences in Diabetes- and TGF-β1-Induced Renal Damage
- (2020) Nadja Ziller et al. Cells
- Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease
- (2020) David J. Miller et al. Antioxidants
- Absence of TGFβ signaling in retinal microglia induces retinal degeneration and exacerbates choroidal neovascularization
- (2019) Wenxin Ma et al. eLife
- Retinal and circulating mi RNA expression patterns in diabetic retinopathy: An in silico and in vivo approach
- (2019) Chiara Bianca Maria Platania et al. BRITISH JOURNAL OF PHARMACOLOGY
- A flibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway
- (2019) Francesca Lazzara et al. BIOCHEMICAL PHARMACOLOGY
- Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients
- (2019) Wen Jeat Ang et al. PLoS One
- Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy
- (2019) Francesco Bandello et al. ACTA DIABETOLOGICA
- Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial
- (2019) Eric Van Cutsem et al. CLINICAL CANCER RESEARCH
- The microenvironment of proliferative diabetic retinopathy supports lymphatic neovascularization
- (2018) Erika Gucciardo et al. JOURNAL OF PATHOLOGY
- Anti–Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
- (2018) Emilia Maggio et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy
- (2018) Chiara Bianca Maria Platania et al. BIOCHEMICAL PHARMACOLOGY
- The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis
- (2018) Gian Tosi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
- (2018) Claudio Bucolo et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Long Non-Coding RNA of Myocardial Infarction Associated Transcript (LncRNA-MIAT) Promotes Diabetic Retinopathy by Upregulating Transforming Growth Factor-β1 (TGF-β1) Signaling
- (2018) Qian Li et al. MEDICAL SCIENCE MONITOR
- Aflibercept in the Treatment of Diabetic Macular Edema: A Review and Consensus Paper
- (2017) Teresio Avitabile et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity
- (2017) Chung-Ying Huang et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA
- (2017) Takao Hirano et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins
- (2017) Eun-Ah Ye et al. VISION RESEARCH
- Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases
- (2017) Hiroki Kaneko et al. Scientific Reports
- The Role of Glycemic Control and Variability in Diabetic Retinopathy
- (2017) Irini P. Chatziralli Diabetes Therapy
- The Role of Glycemic Control and Variability in Diabetic Retinopathy
- (2017) Irini P. Chatziralli Diabetes Therapy
- Aqueous humour concentrations of TGF-β, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy
- (2016) Lee-Anne Khuu et al. ACTA OPHTHALMOLOGICA
- TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers
- (2016) Vincenzo Fisichella et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
- (2016) Pedro Romero-Aroca et al. Journal of Diabetes Research
- The role of CTGF in diabetic retinopathy
- (2015) Ingeborg Klaassen et al. EXPERIMENTAL EYE RESEARCH
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2015) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
- (2015) Chiara B. M. Platania et al. Frontiers in Pharmacology
- Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy
- (2012) Sirpa Loukovaara et al. ACTA OPHTHALMOLOGICA
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- A Possible Role of Acrolein in Diabetic Retinopathy: Involvement of a VEGF/TGFβ Signaling Pathway of the Retinal Pigment Epithelium in Hyperglycemia
- (2012) Jeffery Grigsby et al. CURRENT EYE RESEARCH
- Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now